CTNP方案治疗复发性或难治性非霍奇金淋巴瘤效果观察-3618医疗器械网 关键词】 非霍奇金淋巴瘤,复发性或难治性,CTNP方案 [gap=1023]Key Words] Non-Hodgkin’s lymphoma; Relapsed or Refractory; CTNP protocol
基于88个网页-相关网页
我们在此报道一个II期多中心单一研究项试验，以评价来那度胺口服单一疗法治疗复发性或难治性侵袭性NHL的安全性和有效性。
We report the results of a phase II, single-arm, multicenter trial evaluating the safety and efficacy of lenalidomide oral monotherapy in patients with relapsed or refractory aggressive NHL.
氯法拉滨注射液适用于对至少2种治疗方案无效的儿童(1 - 21岁)难治性或复发性急性淋巴细胞白血病的治疗。
Clofarabine injection is indicated for the treatment of pediatric patients (ages 1-21 years) with relapsed or refractory acute lymphoblastic leukemia after at least 2 previous regimens.
目的：观察eshap方案治疗难治性或复发性非霍奇金淋巴瘤(NHL)的疗效及不良反应。
Objective: to observe the efficacy and the side effect of ESHAP in the treatment of refractory or recurrent Non-Hodgkin's lymphoma (NHL).
应用推荐